Is Adaptimmune Therapeutics plc (ADAP) a Buy, Sell, or Hold?
NASDAQ : ADAP
Adaptimmune Therapeutics plc — Competitors
$0.0485 USD
$0.0 (-3.0%)
- Volume
- 1.68M
- Average Volume
- 110.64M
- Market Capitalization
- $75.16M
- P/E Ratio
- -0.16
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $0.86
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.52
ADAP vs. The Competition
| Properties | ADAP | ANL | APLM | BLRX |
|---|---|---|---|---|
| Market Cap | $75.16M | $704.9M | $18.65M | $11.79M |
| Shares Outstanding | $1.55B | $53.08M | $1.1M | $4.35M |
| P/E Ratio | -0.16 | -8.2 | -2.23 | -1.48 |
| EPS | -0.3 | -1.61 | -25.98 | -0.05 |
| Day Low | 0.0425 | 13.07 | 16.9 | 2.71 |
| Day High | 0.0599 | 14.605 | 17.27 | 2.85 |
| Year Low | 0.0202 | 0.879 | 3.659 | 2.15 |
| Year High | 0.86 | 17.25 | 42.12 | 4.56 |
| Average Price 50 | 0.10275 | 11.3076 | 17.40528 | 3.0844 |
| Average Price 200 | 0.2588 | 7.76494 | 17.47125 | 2.9736 |
| Volume | 1.68M | 270K | 7401 | 6631 |
| Average Volume | - | - | - | - |